Reimagining Vaccine Development with AI
The increasing urgency and frequency of emerging infectious diseases necessitates faster, more agile and scalable vaccine solutions.1 While the rapid spread of health threats is…
AI Drug Development
As New Rules Take Hold, what does ‘Good AI Practice’ look like in Drug Development?
In 2026, setting clear AI expectations is the priority. On January 14, 2026, EMA and FDA marked a step towards regulatory alignment by publishing joint…